Company: BIAF
Filing Date: 2025-04-29
Form Type: 10-K/A
Source: 0001641172-25-006707
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-29
Form: 10-K/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

Amendment No. 1</div>

(Mark One)

| ☒ | ANNUAL                                                                        
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

For the fiscal year ended December 31, 2024.

<div align='center'>OR</div>

| ☐ | TRANSITION                                                                    
 REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

For transition period from ____ to ____.

<div align='center'>Commission file number 001-41463

bioAffinity Technologies, Inc.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                        |     |     46-5211056 |
| (State                                          
 or other jurisdiction                           
 of                                              
 incorporation)                                  |     |        -I.R.S. 
       Employer 
 Identification 
            No. |
| 3300                                            
 Nacogdoches Road, Suite 216, San Antonio, Texas |     |          78217 |
| (Address                                        
 of principal executive offices)                 |     |           -Zip 
           Code |

<div align='center'>(210) 698-5334

(Registrant’s telephone number, including area code)</div>

Securities registered pursuant to Section 12(b) of the Act:

| Title                             
 of each class                     |     | Trading   
 Symbol(s) |     | Name                                 
 of each exchange on which registered |
| Common                            
 stock, par value $0.007 per share |     | BIAF      |     | The                                  
 Nasdaq Stock Market LLC              |
| Tradeable                         
 Warrants to purchase Common Stock |     | BIAFW     |     | The                                  
 Nasdaq Stock Market LLC              |

Securities registered pursuant to section 12(g) of the Act: None.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No☒

Indicate by check mark whether the registrant (1) has filed all reports required